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The major histocompatibility complex codes for determinants which are recognized by 
and serve as targets for cytolytic T lymphocytes (CTL) (1). Antigens coded for by the K 
and D  loci  of the H-2  complex can activate xenogeneic or allogeneic CTL  (2,  3).  In 
addition, the H-2K or H-2D gene products function as those molecules against which 
syngeneic CTL responses specific for chemical, viral, and minor H antigens are directed 
(4-8). 
It has recently been shown that Ia determinants can also serve as target antigens for 
distinct but weaker CTL responses (9-13).  Those clones which recognize Ia antigens see 
them  independently of K-  or D-coded antigens  as  shown  in  genetic studies  and  by 
antisera-blocking experiments (12, 13). We have proposed that the existence of clones of 
CTL specific for I-region-coded determinants is not fortuitous; rather these clones specifi- 
cally recognize Ia determinants and may have an immunoregulatory role. These CTL 
may affect those immune functions which are at least partially dependent on or con- 
trolled by I-region-coded molecules. 
Two predictions can be made and tested concerning the role of Ia determinants 
in cytolytic systems and the role, if any, of I-region-specific CTL in regulating 
the  immune  response:  (a)  that  if as  we  and  others  have  shown,  certain  Ia 
specificities can  serve  as  a  third  series  of major  histocompatibility  antigens, 
then Ia antigens should be susceptible to the same types of antigenic modifica- 
tion  as H-2K-  or H-2D-coded  structures  and  thus  serve  as  targets  for  CTL 
directed against  modified-self in selected systems; and  (b) that allogeneically 
induced/-region-specific CTL should demonstrate cross-reactivity with targets 
bearing modified syngeneic I-region-coded determinants. Data will be presented 
which demonstrates that trinitrophenyl (TNP)-modified syngeneic/-region de- 
terminants can serve as targets for CTL induced by allogeneic Ia antigens. 
Materials  and  Methods 
Mice.  6- to 12-wk-old male and female mice from our own breeding colony or purchased from 
The Jackson Laboratory, Bar Harbor, Maine, were used in these studies. Some A.TL mice were 
the  gift  of Dr.  David  Sachs,  National  Cancer  Institute,  Bethesda,  Md.  The  B10.T(6R)  and 
B10.AQR strains are referred to as 6R and AQR, respectively, throughout this communication. 
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TABLE  I 
CTL to Lyse TNP-Modified  Targets 
%  Specific 
Experiment  Responder  Stimulator  Target*  release of S~Cr 
I  AQR(qkdd)$.  6R(qqqd~  6R-TNP  64.3 
AQR  -  6R-TNP  12.0 
AQR  6R  AQR-TNP  40.0 
AQR  -  AQR-TNP  3.5 
AQR  6R  AQR  -0.3 
2  A.TH(sssd)  A.TL(skkd)  A.TL  18.0 
A,TH  A,TL  A.TH  4.0 
A.TH  A.TL  A.TH-TNP  31.0 
3  AQR  8R  6R  20.5 
AQR  6R  6R.TNP  21.8 
AQR  6R  AQR  1.2 
AQR  6R  AQR-TNP  15.2 
* Effector  to  target ratio  was I00:I.  Spontaneous release of  LPS blast  targets ranged from 30 to 40%. 
Indicates H-2 alleles  for  K,  I,  S, and  D regions. 
Antisera.  Alloantisera were raised by six to eight intraperitoneal injections of lymphoid cells. 
Donor-recipient combinations used and the specificity of each serum are given in the legend to 
Table III. 
Generation of  Effector Cells and the ~LCr-Release Assay.  The method used to generate cytotoxic 
effector cells to allogeneic targets has been described elsewhere (14). TNP coupling of target cells 
was accomplished according to published techniques (15). The 5'Cr-release assay used in this study 
and the method of antisera inhibition have been previously described in detail (15). Lipopolysac- 
charide (LPS)-induced blast spleen cells used as targets in the 51Cr-release assay were produced by 
incubating 4  x  l0  s spleen cells with 10  /~g of LPS in 2 ml of medium consisting of RPMI 1640 
supplemented with 10% heat-inactivated fetal calf serum and glutamine. LPS blasts produced in 
this  fashion were  shown to  contain approximately 80%  Ia-positive  cells by  complement (C)- 
mediated cytotoxicity. 
Percent specific release was calculated as:  [(E  -  C)/(FT  -  C)]  x  100%; where E  is isotope 
release in tubes containing immune effectors plus targets, C is isotope release in tubes containing 
normal spleen cells and targets (spontaneous release), and FT  is maximum isotope release in 
tubes containing targets after freeze-thawing three times. 
Results 
Ability  of TNP-Modified  Syngeneic  Spleen  Cells  to  Act  as  Targets  for I- 
Region-Specific CTL.  Results in Table I illustrate again that CTL induced in 
mixed lymphocyte  culture where the responder and stimulator differ only at the 
I  region of the H-2  complex lyse targets bearing the stimulating allogeneic I 
region. These same CTL also lyse syngeneic  targets which have been chemically 
modified by TNP but will not lyse nonmodified syngeneic  targets. TNP modifica- 
tion of allogeneic/-region-bearing targets did not alter specific release in this 
assay.  Effector cells  which lyse TNP-modified syngeneic and  allogeneic Ia- 
bearing targets are eliminated by anti-Thy 1.2 antiserum plus C (results not 
shown). Therefore, chemical modification of syngeneic cell surface antigens by 
TNP allows CTL directed specifically at/-region-coded alloantigens to lyse these 
cells. 
The magnitude of cytolysis of modified syngeneic/-region-bearing  targets is 
similar to  that  observed on cells expressing allogeneic Ia  antigens used for 
immunization.  In  several experiments at  the  same  effector to  target  ratio 
(100:1), the mean specific lysis of the modified syngeneic target was 89% (_+ 14%) BILLINGS  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE II 
Specificity  of CTL Induced to Allogeneic I-Region Determinants 
625 
Responder TNP-  % Specific 
Experiment  Responder  Stimulator  Target*  target H-2 ident-  release of 
ities$  ~Cr 
1  A.TH(sssd)§  A.TL(skkd)  A(kkdd)  -  68.6 
A.TH  A.TL  A.TH-TNP  K, I, D  53.8 
A,TH  A.TL  ASW-TNP(ssss)  K, I  57.6 
AQR(qkdd)  6R(qqqd)  AQR  1.2 
AQR  6R  6R  21.2 
AQR  6R  AQR.TNP  K, I, D  15.2 
AQR  6R  BIO.BR-TNP(kkkk)  I  15.5 
* Effector  to target  ratio  was 100:1.  Spontaneous release  of  LPS blast  targets  ranged from 35 to  42%. 
~.  H-2 specificities  shared between responder  and TNP-coupled targets,  excluding those products of  the  S region. 
§ Indicates  11.2  alleles  for  K, I, S, and D  regions. 
TABLE  Ill 
Antiserum Blocking of  Cytolysis by CTL Induced to AUogeneic I-Region Determinants* 
Expori- 
Responder  Stimulator  Target~ 
ment 
Antiserum§ 
Contrel  a-I  x  a-D  d 
1  AQR(qhdd)  6R(qqqd)  6R-TNP  21.5  17.5  21.2 
AQR  6R  AQ1LTNP  15.2  3.4  14.0 
AQR  6R  B10.BR-TNP(hkkh)  15.4  2.2  11.5 
2  AQR  6R  6R  28.0  -  - 
AQR  6R  B10.BR-TNP  23.2  -0.2  15.5 
B6  6R  6R  64.2  66.4  37.8 
* Values represent percent specific release of 5~Cr. 
$ Effector to target ratio was 100:1. Spontaneous release of LPS blast targets ranged from 30 to 40%. 
§ Control consisted ofSMEM-10; anti-Ia  ~ antiserum is A.TH anti-A.TL with a lytic titer of 1/1,280; anti-H-2D~ is (B10 × LP.RIII) F~ 
anti-18R with a lyric titer of :>1/640. Both antieera were used at a final dilution of 1:12. 
Indicates 1",1.2 alleles for K, I, S, and D  regions. 
of the lysis on the target bearing the stimulating allogeneic/-region determi- 
nants.  Thus,  under  these  conditions,  clones of CTL  stimulated  by/-region 
differences may recognize TNP-modified syngeneic determinants  as  well  as 
allogeneic Ia antigens on the presented target cells. 
Table I  further illustrates  that culturing responder AQR spleen cells for 5 
days without stimulator cells does not produce effectors which significantly lyse 
either allogeneic or modified syngeneic/-region-bearing targets./-region-spe- 
cific CTL also fail to lyse TNP-modified ACI rat targets (results not shown). 
Specificity and Lack of  H-2K or H-2D Restriction of the Cytolysis of Modified 
Syngeneic  Targets  by I-Region-Specific  CTL.  CTL induced by allogeneic Ia 
antigens show specificity in target lysis for Ia antigens and are not genetically 
restricted by the K  or D  loci of the H-2 complex in effecting this lysis. Table II 
shows that CTL induced to  allogeneic/-region differences lyse TNP-modified 
targets syngeneic at the I region irrespective of the alleles present at the K  or D 
loci. This suggests that this lytic activity is not directed at modified K- or D- 
coded determinants, but at/-region-coded determinants and furthermore, that 
the cytolysis is not restricted by products of the K  or D  loci. 
Table III demonstrates the specificity of modified syngeneic/-region cytolysis 
by antisera blocking. An antiserum specific for/-region-coded products on the 
modified AQR targets blocks the lysis of these targets by AQR/-region-specific 626  BILLINGS  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIG.  1.  Cold  target inhibition of/-region-specific CTL. AQR anti-6R effectors were as- 
sayed on 6R-TNP (left panel) and AQR-TNP (right panel) 5]Cr-labeled  targets. Nonradiola- 
beled AQR (A - &), 6R (I - I), and AQR-TNP (O- 0) spleen cells were used as cold target 
inhibitors at three cold to hot target ratios (100:1, 33:1, and 11:1). Control is lysis without 
cold targets added. Spontaneous  release of LPS-blast targets was 40% for 6R-TNP and 38% 
for AQR-TNP. 
CTL.  In addition,  this serum inhibits the lysis of B10.BR-TNP targets which 
share the I-A subregion with the AQR responder but differ at the K  and D  loci. 
This same  anti-Ia reagent,  while  significantly inhibiting the  lysis of targets 
bearing modified syngeneic/-region-coded determinants,  does not reduce the 
lysis of targets bearing allogeneic Ia antigens used for stimulation. 
An antiserum directed to the products of the H-2D d lOCUS has no effect on the 
lysis of either allogeneic or modified syngeneic targets (bearing d  alleles at the 
D  locus) by CTL induced by allogeneic Ia antigens.  This reagent does signifi- 
cantly reduce the lysis of 6R targets by allogeneic C57BL/6 (B6) CTL which are 
primarily directed at products of the H-2Kq and H-2D ~ loci. 
Thus, both in genetic studies and in antisera-blocking experiments, it can be 
shown that  CTL induced by allogeneic Ia determinants  will specifically lyse 
targets  presenting  TNP-modified  syngeneic  I-region-coded  determinants. 
Clones of CTL induced by allogeneic Ia antigens when presented with targets 
bearing  modified syngeneic K-, I-,  and D-region-coded structures  appear  to 
recognize only the  modified Ia  determinants,  indicating that  these  CTL see 
modified syngeneic Ia antigens specifically and these modified antigens are not 
in association with the products of the K  and D  loci. 
Cold Target Inhibition of I-Region-Directed Cytolysis.  Fig.  1 depicts a  cold 
target inhibition experiment of CTL specific for Ia antigens. The lysis produced 
by AQR anti-6R CTL when tested on a  6R 51Cr-labeled target is significantly 
inhibited by nonradiolabeled 6R (cold) targets in contrast to the slight level of 
inhibition seen  with  AQR TNP-coupled cold targets.  These same  CTL when BILLINGS  ET  AL.  BRIEF  DEFINITIVE  REPORT  627 
tested on a 51Cr-labeled AQR TNP-modified target are inhibited significantly by 
both 6R and  AQR-TNP cold targets.  Therefore,  clones which recognize TNP- 
modified  syngeneic  Ia  determinants  are  a  substantial  subset  of the  clones 
induced by allogeneic/-region  stimulation,  and lyse targets  bearing modified 
syngeneic Ia antigens specifically. 
Discussion  and Summary 
Data presented in this communication support the conclusions that CTL can 
recognize/-region  determinants  on TNP-modified  syngeneic target  cells  and 
that a subset of the clones of CTL induced by allogeneic Ia antigens lyses targets 
bearing TNP-modified syngeneic Ia antigens.  The clones of CTL induced by Ia 
antigen  differences  which  lyse  modified-self Ia  antigen-bearing  targets  are 
distinct  from those  clones primarily  directed at K-  or D-coded determinants. 
Thus, varying the K  or D  alleles of either the stimulator or target cell does not 
significantly  alter the lysis produced by I-region-specific CTL when tested on 
targets  bearing  allogeneic  or  modified  syngeneic  Ia  antigens.  Similarly,  an 
antiserum directed at gene products of the H-2D locus does not reduce the target 
lysis by/-region-specific CTL.  Only an antiserum  specific for Ia determinants 
blocks lysis of CTL induced across I-region differences. When tested on modified 
syngeneic targets, an antiserum specific for syngeneic Ia specificities blocks the 
lysis of these targets by allogeneically induced CTL, while failing to inhibit the 
lysis of targets bearing the stimulating allogeneic I-region determinants.  Added 
to the cold target data, these observations argue that there exists a  significant 
subpopulation in the clones of CTL induced by allogeneic Ia determinants which 
recognize and lyse modified syngeneic Ia-bearing cells. These CTL, when pre- 
sented  with  targets  bearing  modified  K,  I,  and  D  determinants,  recognize 
specifically the modified Ia antigen, though the K- and D-coded products are the 
major target antigens in most cytolytic systems (16). 
Important issues remain to be investigated concerning these I-region-directed 
clones of CTL. If, as we have suggested, they play an immunoregulatory role, 
the target of these T cells may be Ia-bearing cells involved in antigen presenta- 
tion,  in  macrophage-T  cell,  T-T  cell,  or  B-T cell  interactions,  or the  factors 
comprised  in  part  of complexed antigen  and  Ia  determinants  which  seem to 
control  cell-cell  interactions  in  immune  responses.  The  relationship  between 
those Ia determinants which appear to be concerned with the regulation of the 
responses to thymus-dependent antigens and those which serve as targets for I- 
region-directed CTL also remains to be elucidated. 
Received for publication 17 May 1977. 
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